Patent · US Active

Methods for enhancing anti-tumor antibody therapy

US10633450B2 · kind B2 · utility

3Cited by

4References

17Claims

0Family size

Assignee

The Board of Trustees of the Leland Stanford Junior University · US

Inventors

Holbrook Kohrt · San Francisco, US
Roch Houot · Rennes, FR
Ronald Levy · Palo Alto, US
Arash Ash Alizadeh · San Mateo, US
Matthew J. Goldstein · Hillsborough, US
James Torchia · Stanford, US

Key dates

Filing date	Aug 4, 2017
Grant date	Apr 28, 2020
Priority date	—
Expiry date	Mar 21, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70578
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods are provided to enhance the efficacy of antibody therapy directed to tumor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.